Guidance for Industry and FDA Staff

First Page		Document Content
Animal virology Influenza Influenza vaccine Vaccines Neuraminidase inhibitors Orthomyxoviridae Viral disease Avian influenza Metapneumovirus Biology Medicine Health		Guidance for Industry and FDA Staff Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 310,72 KB Share Document on Facebook

	Dear Colleague, The Bill & Melinda Gates Foundation is excited to announce the opening of a new Grand Challenges grant opportunity: Ending the Pandemic Threat: A Grand Challenge for Universal Influenza Vaccine Developmen DocID: 1v6ON - View Document
	Southeast Asian J Trop Med Public Health IMPACT OF NATIONAL INFLUENZA VACCINE CAMPAIGN ON RESPIRATORY ILLNESS IN THAILAND, Patummal Silaporn1 and Suchada Jiamsiri2 DocID: 1uCtR - View Document
	CAMPUS HEALTH CENTER \| 5200 Anthony Wayne Drive, Suite 115, Detroit, MI 48202 \| (QUADRIVALENT INACTIVATED INFLUENZA VACCINE CONSENT NAME: _________________________________________ DOB: __________ DocID: 1uu43 - View Document
	Questions and Answers Vaccine effectiveness estimates for seasonal influenza vaccines February. DocID: 1tpnT - View Document
	HPAI and Vaccine Use The outbreak of highly pathogenic avian influenza (HPAI) H5 in spring 2015 was the worst animal disease outbreak in U.S. history. This disease is extremely deadly to chickens and turkeys and caused s DocID: 1tiKr - View Document